Tianda Pharmaceuticals Limited (HKG:0455)
Hong Kong · Delayed Price · Currency is HKD 0.1200
-0.0010 (-0.83%)
At close: Oct 9, 2026
Tianda Pharmaceuticals Financials Overview
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 350.53 | 322.95 | 329.94 | 532.09 | 546.69 | 509.96 |
Revenue Growth | 8.54% | -2.12% | -37.99% | -2.67% | 7.20% | 7.51% |
Gross Profit Gross Profit Growth | 142.87 | 133.31 | 152.02 | 255.53 | 251.52 | 241.22 |
Operating Income Operating Income Growth | -50.22 | -54.09 | -54.15 | -29.02 | -70.14 | -44.1 |
Net Income Net Income Growth | -69.01 | -70 | -61.37 | -24.16 | -54.64 | -19.77 |
Earnings Per Share EPS Growth | -0.03 | -0.03 | -0.03 | -0.01 | -0.03 | -0.01 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Mar '22 Mar 31, 2022 |
Chinese Medicine Business (Excluding Medical and Healthcare Services) Chinese Medicine Business (Excluding Medical and Healthcare Services) Growth | 77.83 | 59.26 | 29.49 | 51.8 | - | 107.55 |
Medical and Healthcare Services Medical and Healthcare Services Growth | 19.23 | 22.23 | 19.05 | 13.04 | 14.97 | 7.35 |
Pharmaceuticals and Medical Technologies Business (Excluding Chinese Medical Business) Pharmaceuticals and Medical Technologies Business (Excluding Chinese Medical Business) Growth | 259.36 | 249.28 | 285.71 | 471.2 | 462.64 | 396.5 |
Elimination of Intersegment Sales Elimination of Intersegment Sales Growth | -5.89 | -7.82 | -4.32 | -3.94 | -5.14 | -1.45 |
Total Total Growth | 350.53 | 322.95 | 329.94 | 532.09 | 546.69 | 509.96 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 51.55 | 71.41 | 91.83 | 170.87 | 365.17 | 351.9 |
Total Debt Total Debt Growth | 145.34 | 132.66 | 127.45 | 113.6 | 141.05 | 160.43 |
Net Cash (Debt) Net Cash Growth | -93.8 | -61.25 | -35.61 | 57.28 | 224.12 | 191.47 |
Net Cash Growth | - | - | - | -74.44% | 17.06% | 107.15% |
Net Cash Per Share Net Cash Per Share Growth | -0.04 | -0.03 | -0.02 | 0.03 | 0.10 | 0.09 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | -35.28 | 14.04 | -9.7 | -49.76 | 101.9 | -8.23 |
Capital Expenditures CapEx Growth | -1.61 | -6.86 | -20.61 | -49.28 | -33.28 | -53.76 |
Free Cash Flow Free Cash Flow Growth | -36.88 | 7.18 | -30.3 | -99.04 | 68.63 | -61.98 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Mar '22 Mar 31, 2022 |
Gross Margin | 40.76% | 41.28% | 46.08% | 48.02% | 46.01% | 47.30% |
Operating Margin | -14.32% | -16.75% | -16.41% | -5.46% | -12.83% | -8.65% |
Pretax Margin | -19.01% | -21.47% | -16.47% | -4.83% | -11.68% | -5.49% |
Profit Margin | -19.69% | -21.68% | -18.60% | -4.54% | -9.99% | -3.88% |
FCF Margin | -10.52% | 2.22% | -9.18% | -18.61% | 12.55% | -12.16% |
| Fiscal Year | FY 2023 | FY 2022 | FY 2022 |
|---|---|---|---|
| Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Mar '22 Mar 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.003 | 0.003 | 0.003 |
Dividend Per Share Growth | -25.01% | 33.35% | 0% |
Dividend Yield | 1.22% | 0.89% | 1.21% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Mar '22 Mar 31, 2022 |
Forward PE | - | 6.55 | 6.55 | 6.55 | 6.55 | 6.55 |
P/FCF Ratio | - | 38.63 | - | - | 12.69 | - |
PS Ratio | 0.74 | 0.86 | 1.10 | 0.88 | 1.59 | 0.98 |